Clinical Trials Browser

Phase 2 × Uveal Melanoma × Amplified Fragment Length Polymorphism Analysis × Clear all

NCT01217398 2013-08-26

Temozolomide and Bevacizumab in Treating Patients With Metastatic Melanoma of the Eye

Phase 2 Unknown

Uveal Melanoma